HMPV

Clinical trials for HMPV explained in plain language.

Never miss a new study

Get alerted when new HMPV trials appear

Sign up with your email to follow new studies for HMPV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Two-in-One vaccine tested to shield seniors from common respiratory viruses

⭐️ VACCINE ⭐️ Completed

This first-in-human study tested the safety and immune response of a new vaccine designed to protect against two common respiratory viruses, RSV and hMPV, in adults aged 60 to 75. 385 participants received a single injection of either the combined vaccine or an RSV-only vaccine a…

Matched conditions: HMPV

Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 30, 2026 14:29 UTC

HMPV

Get alerted when new HMPV trials appear

New Two-in-One vaccine tested to shield seniors from common respiratory viruses